eras ltd Revenue and Competitors

Diss,

Location

N/A

Total Funding

HRTech

Industry

Estimated Revenue & Valuation

  • eras ltd's estimated annual revenue is currently $6.9M per year.(i)
  • eras ltd's estimated revenue per employee is $126,000

Employee Data

  • eras ltd has 55 Employees.(i)
  • eras ltd grew their employee count by -31% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.5M18-38%N/AN/A
#2
$0.9M11-21%N/AN/A
#3
$36M234N/AN/AN/A
#4
$69M394N/AN/AN/A
#5
$1.2M14-7%N/AN/A
#6
$2.2M2216%N/AN/A
#7
$2.8M294%N/AN/A
#8
$137.6M70229%N/AN/A
#9
$4.6M4146%N/AN/A
#10
$6.2M51-19%$79.5MN/A
Add Company

For more than 30 years, eras have delivered high-quality psychometric solutions for organisations of all sizes from all sectors at local and multi-national locations. By providing clients with our wide range of consultancy services, cutting-edge psychometric tools and associated training, eras has built an extensive client portfolio - see our sample client list. We regularly work in partnership with hundreds of clients across the UK and a handful internationally. As an eras client, you can expect an attentive, flexible approach simultaneously challenging your thinking whilst supporting you throughout our work with you. Whether projects are for one person or 3,000 people, we know and go the extra mile. We also recognise one size does not fit all so our people are picked for the expertise they have in their respective fields. Our highly qualified Consultants and Chartered Occupational Psychologists are among the most experienced in the HR world.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$6.9M

Revenue (est)

-31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

eras ltd News

2022-04-19 - Grand Ole Opry Celebrates The '90s In New Interactive Exhibit

The Grand Ole Opry is going back to one of country's most beloved eras in its new limited-time “Opry Loves The '90s” experience,...

2022-04-13 - Erasca Presents Compelling Preclinical Data Supporting ...

ERAS-601 is a potent and selective small molecule SHP2 inhibitor with ... with available targeted therapies demonstrating limited overall...

2022-04-13 - Elden Ring Would Not Have Been Popular in Other Eras ...

Despite its steep difficulty curve and limited explanations, it is a surprisingly fun experience, with death and discovery behind every...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.7M8411%N/A
#2
$28.6M8919%N/A
#3
$72.6M361N/AN/A
#4
$93M51312%N/A
#5
$75M1001N/AN/A